BioInfra Life Science Inc. (XKON: 266470)
284.00
-2.00 (-0.70%)
Sep 10, 2024, 9:00 AM KST
BioInfra Life Science Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
---|---|---|---|---|---|
Period Ending | Mar '20 Mar 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
Cash & Equivalents | 316.83 | 838.35 | 380.2 | 853.92 | 4,157 |
Short-Term Investments | 7,169 | 7,703 | 75.46 | 280.27 | 0 |
Trading Asset Securities | - | - | 651.66 | 1,500 | 989.69 |
Cash & Short-Term Investments | 7,485 | 8,541 | 1,107 | 2,634 | 5,147 |
Cash Growth | 5407.08% | 671.35% | -57.96% | -48.82% | - |
Accounts Receivable | 1,351 | 1,364 | 1,452 | 1,025 | 379.15 |
Other Receivables | 56.68 | 15.44 | 58.78 | 128.27 | 57.61 |
Receivables | 1,408 | 1,384 | 1,521 | 1,557 | 988.77 |
Prepaid Expenses | 24.43 | 21.53 | 32.95 | 43.56 | 126.88 |
Other Current Assets | 24.59 | 4.78 | 60.58 | 472.83 | 36.66 |
Total Current Assets | 8,942 | 9,951 | 2,722 | 4,708 | 6,299 |
Property, Plant & Equipment | 619.83 | 615.4 | 551.36 | 418.92 | 330.94 |
Long-Term Investments | 611.31 | 578.91 | 560.06 | 1 | - |
Other Intangible Assets | 523.47 | 545.65 | 597.1 | 659.93 | 918.3 |
Other Long-Term Assets | 799.43 | 780.48 | 819.72 | 835.35 | 2,517 |
Total Assets | 11,496 | 12,473 | 5,277 | 6,632 | 10,079 |
Accrued Expenses | 224.54 | 85.05 | 65.6 | 68.73 | 57.99 |
Short-Term Debt | 4,330 | 4,274 | - | - | - |
Current Portion of Long-Term Debt | - | - | - | 636.45 | - |
Current Portion of Leases | 57.82 | 70.86 | - | - | - |
Other Current Liabilities | 749.09 | 884.89 | 637.41 | 441.99 | 208.19 |
Total Current Liabilities | 5,362 | 5,314 | 703.01 | 1,147 | 266.18 |
Long-Term Debt | 6,056 | 6,012 | 447.43 | - | 576.29 |
Long-Term Leases | 10.94 | 14.92 | - | - | - |
Other Long-Term Liabilities | 247 | 250.55 | 268.81 | 24.9 | 71.61 |
Total Liabilities | 12,702 | 12,587 | 2,325 | 2,027 | 1,098 |
Common Stock | 6,762 | 6,762 | 6,738 | 6,493 | 6,407 |
Additional Paid-In Capital | 25,537 | 25,537 | 25,393 | 23,819 | 23,816 |
Retained Earnings | -34,168 | -33,034 | -29,790 | -26,018 | -21,375 |
Comprensive Income & Other | 480.91 | 447.52 | 443.54 | 310.36 | 133.04 |
Total Common Equity | -1,389 | -287.5 | 2,785 | 4,605 | 8,981 |
Minority Interest | 183.4 | 173.68 | 167.72 | - | - |
Shareholders' Equity | -1,206 | -113.82 | 2,953 | 4,605 | 8,981 |
Total Liabilities & Equity | 11,496 | 12,473 | 5,277 | 6,632 | 10,079 |
Total Debt | 10,455 | 10,372 | 447.43 | 636.45 | 576.29 |
Net Cash (Debt) | -2,970 | -1,830 | 659.89 | 1,998 | 4,571 |
Net Cash Growth | - | - | -66.97% | -56.29% | - |
Net Cash Per Share | -220.06 | -135.72 | 48.02 | 154.49 | 358.48 |
Filing Date Shares Outstanding | 13.52 | 13.48 | 15.41 | 12.64 | 12.75 |
Total Common Shares Outstanding | 13.52 | 13.48 | 15.41 | 12.64 | 12.75 |
Working Capital | 3,580 | 4,637 | 2,019 | 3,560 | 6,033 |
Book Value Per Share | -102.70 | -21.33 | 180.72 | 364.35 | 704.36 |
Tangible Book Value | -1,912 | -833.14 | 2,188 | 3,945 | 8,062 |
Tangible Book Value Per Share | -141.41 | -61.82 | 141.97 | 312.13 | 632.33 |
Machinery | 1,496 | 1,417 | 1,319 | 1,037 | 849.05 |
Source: S&P Capital IQ. Standard template. Financial Sources.